Zea Melton
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Phagocytosis and Immune Regulation
- Immune cells in cancer
Papers in
- Oncology 5
- CAR-T cell therapy research 5
-
- Phagocytosis and Immune Regulation 1
- Co-authors
- Thomas Van BlarcomJavier Chaparro‐RiggersKevin C. LindquistBarbra J. SasuYvonne S.L. MakJonathan R. HeyenSheng DingShahram Salek‐Ardakani
- Journals
- Clinical Cancer Research (1 paper)Nature Communications (1 paper)Journal of Molecular Biology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Cancer Immunology Research (1 paper)
- Partner nations
- United StatesSwitzerlandParaguay
In The Last Decade
Zea Melton
8 papers receiving 282 citations
Peers
Comparison fields: 5 of 40
- Oncology 165
- Immunology 120
- Radiology, Nuclear Medicine and Imaging 66
- Molecular Biology 113
- Biotechnology 13
Countries citing papers authored by Zea Melton
This map shows the geographic impact of Zea Melton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zea Melton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zea Melton more than expected).
Fields of papers citing papers by Zea Melton
This network shows the impact of papers produced by Zea Melton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zea Melton. The network helps show where Zea Melton may publish in the future.
Co-authors
The 25 scholars most cited alongside Zea Melton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 31 | |
| 2 | 2022 | 6 | |
| 3 | 2022 | 57 | |
| 4 | 2021 | 96 | |
| 5 | 2021 | 38 | |
| 6 | 2019 | 2 | |
| 7 | 2018 | 8 | |
| 8 | 2014 | 50 |
About Zea Melton
Zea Melton is a scholar working on Oncology, Immunology, Biotechnology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering, having authored 8 papers that have together received 288 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Nanowire Synthesis and Applications (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Glycosylation and Glycoproteins Research (1 paper), Bacteriophages and microbial interactions (1 paper), CRISPR and Genetic Engineering (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Oncology (165 citations), Immunology (120 citations), Radiology, Nuclear Medicine and Imaging (66 citations), Molecular Biology (113 citations) and Biotechnology (13 citations). Zea Melton has collaborated with scholars based in United States, Switzerland and Paraguay. Frequent co-authors include Thomas Van Blarcom, Javier Chaparro‐Riggers, Kevin C. Lindquist, Barbra J. Sasu, Yvonne S.L. Mak, Jonathan R. Heyen, Sheng Ding, Shahram Salek‐Ardakani, Wenjing Yang and Pawel K. Dominik. Their work appears in journals such as Clinical Cancer Research, Nature Communications, Journal of Molecular Biology, Journal for ImmunoTherapy of Cancer and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.